Sudarshan Pharma Industries Ltd — Others, 12-06-2025: AGM/EGM

Sudarshan Pharma Industries Ltd has announced a board meeting to approve the financial results for the quarter and half-year. The company also held an Extraordinary General Meeting through video conferencing, where shareholders approved increasing borrowing and charge creation limits up to Rs 2,500 Cr. Additionally, various related party transactions with its wholly-owned subsidiaries and associates were approved, reflecting ongoing strategic and operational alignment within the group. These actions enhance the company’s financial flexibility and support its business growth and governance framework, providing clarity and confidence to shareholders.